Lifeward Ltd.
About Lifeward Ltd.
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions spanning the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings include the ReWalk Personal Exoskeleton, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. The company operates in the United States, which generates the majority of its revenue, as well as in Europe, Germany, Asia Pacific, and the rest of the world.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $1.4M
- Net income
- -$19.9M
- Total assets
- $22.9M
- Market cap
- $19.7M
- Gross margin
- 38.2%
- Operating margin
- -89.3%
- Net margin
- 90.3%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $22.0M
- Cost of revenue
- $13.6M
- Gross profit
- $8.4M
- Operating expenses
- $28.1M
- Operating income
- -$19.7M
- Income tax
- -$55.0K
- Net income
- $19.9M
- EPS (basic)
- $-17.16
- EPS (diluted)
- $-17.16
Balance sheet
- Total assets
- $22.9M
- Current assets
- $15.8M
- Total liabilities
- $14.5M
- Current liabilities
- $12.0M
- Shareholders’ equity
- $8.4M
Cash flow
- Operating cash flow
- -$16.8M
- Investing cash flow
- -$16.0K
- Financing cash flow
- $12.2M
- Net cash flow
- -$4.6M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $19.7M
- EPS (diluted)
- $-17.16
- Shares outstanding
- 2.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 12, 2014
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $19.9M in FY2025.
- Revenue declined 14% from FY2024 to FY2025.
- Gross margin of 38.2%, net margin 90.3%.
- Trading 60% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Lifeward Ltd..
Write a review
News about Lifeward Ltd.
News & sentiment via Polygon.io
